147.55
前日終値:
$148.22
開ける:
$148.395
24時間の取引高:
2.36M
Relative Volume:
0.95
時価総額:
$36.28B
収益:
$222.29B
当期純損益:
$1.56B
株価収益率:
23.02
EPS:
6.41
ネットキャッシュフロー:
$2.44B
1週間 パフォーマンス:
-2.79%
1か月 パフォーマンス:
+12.13%
6か月 パフォーマンス:
+19.63%
1年 パフォーマンス:
+48.45%
Cardinal Health Inc Stock (CAH) Company Profile
CAH を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
CAH
Cardinal Health Inc
|
147.59 | 36.28B | 222.29B | 1.56B | 2.44B | 6.41 |
![]()
MCK
Mckesson Corporation
|
676.25 | 88.38B | 359.05B | 3.30B | 5.23B | 25.83 |
![]()
COR
Cencora Inc
|
274.87 | 56.56B | 310.23B | 1.69B | 3.58B | 8.62 |
![]()
HSIC
Henry Schein Inc
|
70.00 | 8.10B | 12.50B | 314.00M | 421.00M | 2.44 |
![]()
OMI
Owens Minor Inc
|
7.18 | 626.70M | 10.42B | -38.77M | 323.54M | -0.51 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-02-05 | アップグレード | Jefferies | Hold → Buy |
2025-01-08 | アップグレード | TD Cowen | Hold → Buy |
2025-01-07 | アップグレード | Evercore ISI | In-line → Outperform |
2025-01-06 | アップグレード | BofA Securities | Neutral → Buy |
2024-12-13 | アップグレード | Wells Fargo | Underweight → Equal Weight |
2024-12-04 | 再開されました | Mizuho | Outperform |
2024-02-26 | 開始されました | Leerink Partners | Outperform |
2024-02-09 | アップグレード | Argus | Hold → Buy |
2024-01-03 | 開始されました | Barclays | Overweight |
2023-12-14 | 開始されました | Wells Fargo | Underweight |
2023-07-10 | ダウングレード | Evercore ISI | Outperform → In-line |
2023-03-31 | 開始されました | Citigroup | Neutral |
2023-02-03 | アップグレード | Robert W. Baird | Neutral → Outperform |
2022-11-04 | アップグレード | BofA Securities | Underperform → Neutral |
2022-08-22 | 再開されました | Morgan Stanley | Overweight |
2022-05-26 | ダウングレード | Barclays | Overweight → Equal Weight |
2022-05-18 | アップグレード | Evercore ISI | In-line → Outperform |
2022-04-12 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2022-04-01 | 再開されました | Credit Suisse | Neutral |
2021-08-06 | ダウングレード | Deutsche Bank | Buy → Hold |
2021-08-05 | ダウングレード | BofA Securities | Buy → Underperform |
2021-05-10 | ダウングレード | Robert W. Baird | Outperform → Neutral |
2021-01-08 | アップグレード | Wolfe Research | Underperform → Peer Perform |
2020-11-02 | アップグレード | Barclays | Equal Weight → Overweight |
2020-09-25 | アップグレード | Deutsche Bank | Hold → Buy |
2020-07-20 | アップグレード | Guggenheim | Neutral → Buy |
2020-05-15 | アップグレード | UBS | Neutral → Buy |
2020-04-23 | 再開されました | Credit Suisse | Neutral |
2020-03-20 | アップグレード | BofA/Merrill | Underperform → Buy |
2020-02-12 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
2020-02-07 | アップグレード | Robert W. Baird | Neutral → Outperform |
2019-12-16 | ダウングレード | Guggenheim | Buy → Neutral |
2019-09-12 | 開始されました | Deutsche Bank | Hold |
2019-08-27 | ダウングレード | Argus | Buy → Hold |
2019-08-20 | アップグレード | Guggenheim | Neutral → Buy |
2019-04-18 | 開始されました | Guggenheim | Neutral |
2019-01-17 | 開始されました | UBS | Neutral |
2018-11-16 | ダウングレード | Leerink Partners | Outperform → Mkt Perform |
2018-04-24 | アップグレード | Leerink Partners | Mkt Perform → Outperform |
2018-04-02 | アップグレード | Argus | Hold → Buy |
2018-03-08 | 開始されました | Barclays | Equal Weight |
2018-02-27 | 再開されました | BofA/Merrill | Underperform |
2018-01-05 | 開始されました | Evercore ISI | In-line |
すべてを表示
Cardinal Health Inc (CAH) 最新ニュース
Cardinal Health (CAH): Navigating Market Uncertainty | CAH Stock News - GuruFocus
Cardinal Health (CAH) Faces Market Focus Amid Global Trade Talks - GuruFocus
JPMorgan Adjusts Cardinal Health Price Target to $156 From $145, Maintains Neutral Rating - marketscreener.com
Cardinal Health's (NYSE:CAH) Shareholders Will Receive A Bigger Dividend Than Last Year - simplywall.st
Cardinal Health (NYSE:CAH) Has Announced That It Will Be Increasing Its Dividend To $0.5107 - Yahoo Finance
Cardinal Health, Inc. (CAH): Among Billionaire Mason Hawkins’ Mid-Cap Stocks with Huge Upside Potential - Insider Monkey
-Charles River agrees with Elliott to add new directors, review business - marketscreener.com
Charles River to add new directors, review business in agreement with Elliott - marketscreener.com
Cardinal Health releases new report on the cell and gene therapy industry | CAH Stock News - GuruFocus
Cardinal Health releases new report on the cell and gene therapy industry - Stock Titan
Cardinal Health (NYSE:CAH) Announces Dividend Increase to US$1 Per Share - simplywall.st
Cardinal Health Board of Directors Approves Quarterly Dividend | - GuruFocus
Cardinal Health (CAH) Boosts Quarterly Dividend and Revises Earnings Guidance - GuruFocus
Cardinal Health Raises Dividend by About 1% - MarketWatch
Cardinal Health raises quarterly dividend to $0.5107 By Investing.com - Investing.com Canada
Cardinal Health Board of Directors Approves Quarterly Dividend - GuruFocus
Cardinal Health Increases Quarterly Dividend to $0.5107 a Share From $0.5056, Payable July 15 to Investors of Record July 1 - marketscreener.com
Cardinal Health Board of Directors Approves Quarterly Dividend | CAH Stock News - GuruFocus
Cardinal Health (CAH) Stock Target Price Increased by Morgan Stanley | CAH Stock News - GuruFocus
Argus Elevates Price Target for Cardinal Health (CAH) Amid Strat - GuruFocus
Are Investors Undervaluing Cardinal Health (CAH) Right Now? - Yahoo Finance
Cardinal Health (CAH) Price Target Increased by Morgan Stanley | - GuruFocus
Argus Adjusts Price Target on Cardinal Health to $162 From $148 - marketscreener.com
Cardinal Health’s Promising Growth Under New Leadership Justifies Buy Rating - TipRanks
Cardinal Health, Northrop Grumman Among 7 Companies To Announce Dividend Increases In First Half Of May - Seeking Alpha
Cardinal Health Third Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance
Cardinal Health (CAH): Analyst Raises Price Target Amid Strong P - GuruFocus
Cardinal Health (CAH): Analyst Raises Price Target Amid Strong Performance | CAH Stock News - GuruFocus
Cardinal Health cuts employees to offset up to $300M tariff charge - MedTech Dive
Cardinal Health CEO Jason Hollar on rising profits, record stock price - The Business Journals
Cardinal Health reports Q3 results, raises 2025 outlook - Drug Store News
UBS Elevates Price Target for Cardinal Health (CAH) to $170 | CA - GuruFocus
Cardinal Health (CAH) Price Target Raised by Baird Analyst | CAH Stock News - GuruFocus
UBS Elevates Price Target for Cardinal Health (CAH) to $170 | CAH Stock News - GuruFocus
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term - Yahoo Finance
Cardinal Health (CAH) Price Target Increased by Baird Analyst | - GuruFocus
Cardinal Health, Inc. (NYSE:CAH) Q3 2025 Earnings Call Transcript - MSN
Cardinal Health (CAH) Price Target Increased by Baird Analyst | CAH Stock News - GuruFocus
Cardinal Health Reaches Analyst Target Price - Nasdaq
Medtech companies try to head off price increases after tariffs - Modern Healthcare
Decoding Cardinal Health Inc (CAH): A Strategic SWOT Insight - GuruFocus
Cardinal Health Inc (CAH) Q3 2025 Earnings Call Highlights: Strong Earnings Growth and Raised ... - Yahoo Finance
Cardinal Health Inc (CAH) Q3 2025 Earnings Call Highlights: Stro - GuruFocus
Cardinal Health Lifts FY25 EPS Outlook, Sees Growth Despite Tariff Risks - AOL.com
Cardinal Health Inc (CAH) Q3 2025 Earnings Call Highlights: Strong Earnings Growth and Raised Guidance - GuruFocus
Cardinal Health raises FY 2025 EPS guidance to $8.05-$8.15 amid strong pharma growth and acquisitions - MSN
Cardinal Health (CAH) Boosts 2025 Outlook Following Strong Q3 - GuruFocus
Cardinal Health’s Earnings Call Highlights Growth and Challenges - TipRanks
Citi Increases Price Target for Cardinal Health (CAH) After Robu - GuruFocus
Citi Increases Price Target for Cardinal Health (CAH) After Robust Q3 Performance | CAH Stock News - GuruFocus
Cardinal Health Reports Third Quarter Fiscal Year 2025 Results a - GuruFocus
Cardinal Health Inc (CAH) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):